Vivek Sir'S Physiology (Vsp) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -731.45%
- Ebitda -1457.60%
- Net Worth -89.31%
- Total Assets 92.80%
About Vivek Sir'S Physiology (Vsp)
Vivek Sir's Physiology (Vsp) Private Limited (VSPVPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 February 2021 (Three years and 11 months 22 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Education & Learing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bharati Nalgirkar and Vivek Nalgirkar serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U80903MH2021PTC354744
- Company No.
354744
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2021
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Vivek Sir'S Physiology (Vsp)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharati Nalgirkar  | Director | 08-Feb-2021 | Current |
| Vivek Nalgirkar | Director | 08-Feb-2021 | Current |
Financial Performance of Vivek Sir'S Physiology (Vsp).
Vivek Sir'S Physiology (Vsp) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 731.45% decrease in profit. The company's net worth observed a substantial decline by a decrease of 89.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vivek Sir'S Physiology (Vsp)?
Unlock access to Vivek Sir'S Physiology (Vsp)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Paras Organics Private LimitedVivek Nalgirkar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vivek Sir'S Physiology (Vsp)?
Vivek Sir'S Physiology (Vsp) has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vivek Sir'S Physiology (Vsp), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivek Sir'S Physiology (Vsp)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.